Koninklijke Philips (PHG) Operating Income Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45.40% |
| Dec 31, 2025 | -4.22% |
| Sep 30, 2025 | -3.56% |
| Jun 30, 2025 | 14.93% |
| Mar 31, 2025 | 74.77% |
| Dec 31, 2024 | 54.72% |
| Sep 30, 2024 | -18.32% |
| Jun 30, 2024 | -15.12% |
| Mar 31, 2024 | -39.14% |
| Dec 31, 2023 | -19.15% |
| Sep 30, 2023 | -26.08% |
| Jun 30, 2023 | -25.46% |
| Mar 31, 2023 | -35.30% |
| Dec 31, 2022 | -145.03% |
| Sep 30, 2022 | -29.57% |
| Jun 30, 2022 | -53.57% |
| Mar 31, 2022 | -22.73% |
| Dec 31, 2021 | 10.97% |
| Sep 30, 2021 | -13.30% |
| Jun 30, 2021 | -25.36% |
| Mar 31, 2021 | -17.98% |
| Dec 31, 2020 | -6.43% |
| Sep 30, 2020 | 3.99% |
| Jun 30, 2020 | -10.15% |
| Mar 31, 2020 | -42.43% |
| Dec 31, 2019 | -17.74% |
| Jun 30, 2018 | -19.64% |
| Mar 31, 2018 | -9.38% |
| Dec 31, 2017 | -15.11% |
| Sep 30, 2017 | -1.97% |
| Jun 30, 2017 | -5.76% |
| Mar 31, 2017 | -10.35% |
| Dec 31, 2016 | 18.16% |
| Sep 30, 2016 | 25.77% |
| Jun 30, 2016 | 18.96% |
| Mar 31, 2016 | -12.83% |
| Dec 31, 2015 | 0.12% |
| Sep 30, 2015 | -10.78% |
| Jun 30, 2015 | -4.66% |
| Mar 31, 2015 | -21.52% |
| Dec 31, 2014 | -5.82% |